The best consulting relationship is one that eventually ends.

When I start working with a biomarker team, my goal isn't to create dependency—it's to build their independence.

Here's what that looks like:

✅ I teach you to evaluate biomarkers yourself. Not just "this looks promising" but understanding statistical power, dynamic range, and clinical robustness. You learn to spot the red flags before they derail your Phase 2.

✅ I show you how to build comprehensive strategies. Beyond picking assays and providers. How to plan for staff turnover, timeline dependencies, and regulatory milestones. The kind of documentation that survives team changes.

✅ I connect you with the right resources. FDA guidance documents that actually matter. Which conferences to attend. Key opinion leaders worth knowing. The biomarker community isn't huge—knowing who to call saves months.

✅ I help you recognize when you're ready. Some teams graduate after 6 months. Others need 18. It depends on your stage, complexity, and internal expertise. But the goal is always the same: confident independence.

The best part of my job? Getting that message months later: "We're handling the next program ourselves. Thanks for teaching us how to think about this."
That's precision medicine strategy done right.